Back to search
FDAFDA · Food and drugs·Recall number D-0288-2019

Euphoric Premium Male Performance Enhancer capsules, packaged in a)1-count blister cards, UPC 6 96859 28646 9, b) 3-count bottle, UPC 6 96859 28647 6 and c) 12-count bottle, UPC 6 96859 28648 3.

Published November 21, 2018 · Recall initiated: April 16, 2018

Summary

FDA records drug Class I recall D-0288-2019, published November 21, 2018 and initiated April 16, 2018. Recalling firm: Epic Products, LLC; Status: Terminated; Reported quantity: a) 106,329 cards; b) 109,725 bottles; c) 28,644 bottles; Lot: All lots. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed Without An Approved NDA/ANDA: product contains undeclared sildenafil, tadalafil, and oxytetracycline, FDA approved drug products making Euphoric an unapproved drug.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Epic Products, LLC
Distributor
Nationwide in the USA
Lot
All lots
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Euphoric Premium Male Performance Enhancer capsules, packaged in a)1-count blister cards, UPC 6 96859 28646 9, b) 3-count bottle, UPC 6 96859 28647 6 and c) 12-count bottle, UPC 6 96859 28648 3. recalled?

Yes. FDA published recall D-0288-2019 on November 21, 2018. Reported hazard: Marketed Without An Approved NDA/ANDA: product contains undeclared sildenafil, tadalafil, and oxytetracycline, FDA approved drug products making Euphoric an unapproved drug.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release